About BioClonetics

BioClonetics is a biotechnology company engaged in the discovery, acquisition and development of proprietary pharmaceutical compounds and new technologies for use in the diagnosis and treatment of HIV/AIDS and other infectious diseases.

BioClonetics has created a human cell line that produces a human antibody (designated as CLONE 3) that neutralizes HIV, the virus that causes AIDS. As its primary... more info
 
 
News Updates

South Africa fighting 1,500 new HIV infections a day. more...
Quick Contact

BioClonetics Immunotherapeutics, Inc.
Paul D. Fellegy
(979) 492-3572


For More Information Click here.
 
 
© Copyright 2013, BioClonetics Immunotherapeutics, Inc. All Rights Reserved.
Home  |  Overview  |  Technology  |  Intellectual Property  |  Partners  |  Management Team  |  Contact Us
Website Design by Dallas Web Designer Red Spot Design